Ditropan and Botox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ditropan (oxybutynin chloride) and Botox (botulinum toxin type a). Common drug interactions include basal cell carcinoma among females and dysgeusia among males.

The phase IV clinical study analyzes what interactions people have when they take Ditropan and Botox. It is created by eHealthMe based on reports of 60 people who take the same drugs from the FDA, and is updated regularly.

What is Ditropan?

Ditropan has active ingredients of oxybutynin chloride. It is often used in urge incontinence. eHealthMe is studying from 11,799 Ditropan users. Check the latest studies of Ditropan.

What is Botox?

Botox has active ingredients of botulinum toxin type a. It is often used in migraine. eHealthMe is studying from 70,513 Botox users. Check the latest studies of Botox.

On Jul, 31, 2026

60 people who take Ditropan and Botox together, and have interactions are studied.

What are the common drug interactions of Ditropan and Botox, by gender? *:

female:

Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Neurogenic bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion)
Osteonecrosis (death of bone)
Postnasal drip
Vaginal haemorrhage (vaginal bleeding)
Arthralgia (joint pain)
Exophthalmos (bulging or protruding eyeball)
Muscle spasms (muscle contraction)
Back pain
Blepharitis (chronic inflammation of the eyelid)

male:

Dysgeusia (disorder of the sense of taste)
Dyspnoea (difficult or laboured respiration)
Diarrhoea
Eating disorder
Fatigue (feeling of tiredness)
Loss of consciousness
Dysphagia (a condition in which swallowing is difficult or painful)
Rash
Altered state of consciousness (altered state of mind)
Blood pressure increased

What are the common drug interactions of Ditropan and Botox, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Electrocardiogram qt prolonged

20-29:

n/a

30-39:

Dyspnoea (difficult or laboured respiration)
Muscular weakness (muscle weakness)
Dysarthria (speech disorder)
Dysphagia (a condition in which swallowing is difficult or painful)
Asthenia (weakness)

40-49:

Dehydration (dryness resulting from the removal of water)
Fatigue (feeling of tiredness)
Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Muscle spasticity (tight or stiff muscles and an inability to control those muscles)
Muscular weakness (muscle weakness)
Procedural nausea
Procedural pain
Septic shock (shock due to blood infection)
Complication of device insertion
Asthenia (weakness)

50-59:

Pain
Rash
Abdominal pain upper
Cystitis (inflammation of the wall of the bladder)
Headache (pain in head)
Hospitalisation
Hypotonia (low muscle tone)
Mobility decreased (ability to move is reduced)
Muscle spasticity (tight or stiff muscles and an inability to control those muscles)
Oropharyngeal pain

60+:

Weight decreased
Urinary tract infection
Depression
Escherichia infection (bacterial infection by escherichia coli)
Eye disorder
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
General physical condition
Haematoma (collection of blood outside the blood vessels)
Hypertonic bladder (bladder-storage function that causes a sudden urge to urinate)
Impaired healing

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 13 people, 21.67%
Pain: 8 people, 13.33%
Neurogenic Bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion): 8 people, 13.33%
Constipation: 7 people, 11.67%
Gait Disturbance: 5 people, 8.33%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 4 people, 6.67%
Hypersensitivity: 4 people, 6.67%
Urinary Tract Infection: 4 people, 6.67%
Muscle Spasms (muscle contraction): 3 people, 5.00%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 3 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ditropan and Botox?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously